Pharmacytimes: Condition Center: Hepatitis C Hepatitis C en-us Tue, 31 Mar 2015 12:24:04 UTC Tue, 31 Mar 2015 12:24:04 UTC Researchers Identify How Hepatitis Leads to Liver Cancer A recent study has identified how chronic hepatitis infection can pave the way to liver cancer. Fri, 06 Feb 2015 04:18:00 UTC How Hepatitis C Therapies are Changing Patient Treatment Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how hepatitis C therapies are changing patient treatment. Fri, 09 Jan 2015 07:48:40 UTC More Awareness of Hepatitis C Patients Needed A new study has revealed that many patients infected with the hepatitis C virus do not seek treatment and become lost in the different stages of health care to manage the disease. Wed, 24 Dec 2014 01:32:55 UTC Researchers Set to Study Hepatitis C Therapy in Children Researchers from Saint Louis University Medical Center will test the safety and efficacy of sofosbuvir and ribavirin in children with hepatitis C. Sat, 04 Oct 2014 01:40:59 UTC Polypharmacy Hinders HIV Drug Adherence Among HIV-positive patients, concurrent use of medications is associated with nonadherence to antiretroviral therapy. Sat, 27 Sep 2014 04:33:01 UTC Combination Treatment for HIV/HCV Coinfection Shown Effective in Phase 3 Trial Results of a phase 3 trial demonstrate the effectiveness of simeprevir in combination with ribavirin and peginterferon as a treatment for patients coinfected with HIV and HCV. Tue, 16 Sep 2014 02:56:43 UTC Hepatitis C Patients with HIV Co-Infection Vulnerable to Serious Liver Disease Despite Antiretroviral Therapy A study finds that patients co-infected with hepatitis C and HIV who are receiving antiretroviral therapy are 80% more likely to have serious liver disease than those with hepatitis C alone. Fri, 23 May 2014 01:00:54 UTC Multiple Tactics Needed to Combat Hepatitis C in Young Drug Users With hepatitis C infections on the rise among young injection drug users, researchers have recommended a range of promising prevention tactics. Wed, 07 Aug 2013 04:16:31 UTC Task Force Recommends Hepatitis C Testing for Baby Boomers The U.S. Preventive Services Task Force recommends that all patients born between 1945 and 1965 as well as high-risk patients of all ages be tested for hepatitis C. Tue, 09 Jul 2013 07:57:10 UTC CDC Urges All Baby Boomers to Get Tested for Hepatitis C Testing baby boomers could help identify more than 800,000 new cases of hepatitis C and address the largely preventable consequences of the condition. Fri, 08 Jun 2012 04:46:49 UTC Triple Therapy for Hepatitis C Can Be Cost-Effective New triple-therapy regimens for hepatitis C are expensive, but they can be cost-effective for many patients. Mon, 27 Feb 2012 05:20:09 UTC Risk Factors for Hepatitis C Fri, 24 Feb 2012 06:43:17 UTC New Drugs for Hepatitis C Fri, 24 Feb 2012 06:27:22 UTC The Promise of Interferon-Free Treatment Regimens for Hepatitis C Fri, 24 Feb 2012 05:37:42 UTC New Hepatitis C Treatment Fri, 24 Feb 2012 04:53:59 UTC Hepatitis C: Know Your Status Fri, 24 Feb 2012 04:43:42 UTC Hepatitis C: The Basics Fri, 24 Feb 2012 04:31:20 UTC All-Oral Hepatitis C Treatment in Trial Could treatment for hepatitis C viral infection become an all-oral supplement? Tue, 21 Feb 2012 02:00:01 UTC Hepatitis C Virus Infection Caused in Transplant Recipients Organs and tissue donated by a Kentucky man infected with the hepatitis C virus causes disease transmission to multiple organ recipients. Tue, 21 Feb 2012 02:00:00 UTC Bringing Viral Hepatitis Federal Action Plan to Life The Department of Health and Human Services action plan calls for better strategies and methods of treating and diagnosing viral hepatitis. Tue, 21 Feb 2012 02:00:00 UTC